Skip to main content
. 2020 Mar 27;12(9):853–860. doi: 10.1002/pmrj.12348

Figure 1.

Figure 1

Patient population. AboBoNT‐A, abobotulinumtoxinA; BoNT‐A, botulinum toxin A; max, maximum. *Some patients had previously been treated with more than one other BoNT‐A product. Patient flow is presented for the safety population. Previous BoNT‐A treatments are presented for the intention‐to‐treat population.